Abstract
Wendell A Wilson
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The epidemiology of systemic lupus erythematosus in populations of African Ancestry. A critical review of the ‘prevalence gradient hypotheses’
10.1002/1529-0131(199812)41:12<2091::aid-art2>3.0.co;2-d · 1998
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
10.1016/s0140-6736(83)91267-9 · 1983
Antiphospholipid antibodies: Isotype distribution and phospholipid specificity
10.1136/ard.46.1.1 · 1987
Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with SLE
10.1056/nejm198507183130304 · 1985
The ‘primary’ antiphospholipid syndrome: major clinical and serological features
10.1097/00005792-198911000-00004 · 1989
Primary antiphospholipid syndrome
1989
Cardiolipin antibodies and null alleles of C4 in black Americans with systemic lupus erythematosus
1988
Anticardiolipin antibodies in unselected pregnant women: relationship to fetal outcome
1991
Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus
1997
The ‘primary’ antiphospholipid syndrome: Antiphospholipid antibody pattern and clinical features of a series of 23 patients
10.3109/08916939108997126 · 1991
Renal involvement in primary antiphospholipid syndrome
1992
Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus
10.1136/ard.50.3.173 · 1991
MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus
1996
Prevalence and clinical associations of anticardiolipin antibodies in patients with systemic lupus erythematosus in India
1990
Occasional series—lupus around the world. Systemic Lupus Erythematosus in India
10.1177/096120339700600903 · 1997
Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations
10.1016/s0002-9343(99)80249-6 · 1995
Cutaneous manifestations of Hughes syndrome occurring in the context of lupus erythematosus
10.1177/096120339700600209 · 1997
Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus
10.1002/art.1780390905 · 1996
Clinical features associated with a positive anticardiolipin antibody in Irish patients with systemic lupus erythematosus
10.1007/bf02229642 · 1996
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies in patients with in systemic lupus erythematosus: comparison between Colombians and Spaniards
10.1191/096120399678847533 · 1999
Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype
10.1191/096120399678847812 · 1999
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop
10.1002/1529-0131(199907)42:7<1309::aid-anr1>3.0.co;2-f · 1999
Validation of the Sapporo Criteria for antiphospholipid syndrome
10.1002/1529-0131(200002)43:2<440::aid-anr26>3.0.co;2-n · 2000
Significance of IgA antiphospholipid antibodies
10.1177/096120339800700225 · 1998
Genetic risk factors for aPL Syndrome
10.1177/096120339600500513 · 1996
No additional external references are available.